By Alex Baldwin ( August 22, 2023, 6:10 PM BST) -- Janssen Biotech Inc. has denied claims that a U.K. patent protecting its immunosuppressant Stelara is invalid, in a now-trimmed legal action brought by rival Amgen Inc. targeting patent protections for the blockbuster drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.